IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,821,635 | -10.3% | 3,719,796 | -0.8% | 0.55% | -3.0% |
Q2 2023 | $39,917,003 | -3.5% | 3,751,598 | -4.6% | 0.57% | -8.6% |
Q1 2023 | $41,384,975 | -16.4% | 3,933,933 | -1.6% | 0.62% | -24.4% |
Q4 2022 | $49,523,388 | -44.7% | 3,997,045 | -53.7% | 0.82% | -34.7% |
Q3 2022 | $89,481,000 | -33.3% | 8,637,118 | -25.8% | 1.26% | -30.2% |
Q2 2022 | $134,232,000 | -25.0% | 11,641,935 | -18.2% | 1.80% | +0.9% |
Q1 2022 | $179,001,000 | -5.6% | 14,228,999 | -12.5% | 1.78% | +13.6% |
Q4 2021 | $189,567,000 | -14.6% | 16,257,899 | -4.4% | 1.57% | -13.8% |
Q3 2021 | $222,077,000 | -6.7% | 17,004,395 | -8.0% | 1.82% | +0.9% |
Q2 2021 | $237,899,000 | +5.5% | 18,484,759 | -8.4% | 1.80% | +7.4% |
Q1 2021 | $225,502,000 | -1.7% | 20,170,126 | +0.1% | 1.68% | +5.9% |
Q4 2020 | $229,514,000 | +26.9% | 20,150,463 | +0.2% | 1.59% | +5.8% |
Q3 2020 | $180,829,000 | -6.8% | 20,103,292 | +6.9% | 1.50% | -10.1% |
Q2 2020 | $193,996,000 | +7.0% | 18,798,061 | +4.7% | 1.67% | -20.6% |
Q1 2020 | $181,225,000 | -23.9% | 17,960,849 | +0.3% | 2.10% | -7.8% |
Q4 2019 | $238,263,000 | +54.8% | 17,901,053 | -0.2% | 2.28% | +52.5% |
Q3 2019 | $153,936,000 | +14.1% | 17,930,781 | +45.4% | 1.49% | +16.8% |
Q2 2019 | $134,889,000 | -3.5% | 12,329,890 | +19.4% | 1.28% | -9.5% |
Q1 2019 | $139,719,000 | +33.1% | 10,326,638 | +1.9% | 1.41% | +11.9% |
Q4 2018 | $104,940,000 | -11.9% | 10,129,331 | +57.1% | 1.26% | +16.8% |
Q3 2018 | $119,058,000 | -1.2% | 6,449,511 | +2.3% | 1.08% | -12.6% |
Q2 2018 | $120,560,000 | +24.7% | 6,305,456 | +0.6% | 1.24% | +12.7% |
Q1 2018 | $96,666,000 | +3.0% | 6,264,825 | +0.0% | 1.10% | -3.7% |
Q4 2017 | $93,895,000 | -4.2% | 6,263,825 | +0.7% | 1.14% | -4.4% |
Q3 2017 | $98,051,000 | -16.5% | 6,217,575 | +0.0% | 1.19% | -17.0% |
Q2 2017 | $117,359,000 | +35.1% | 6,216,074 | +22.1% | 1.44% | +24.2% |
Q1 2017 | $86,854,000 | – | 5,091,074 | – | 1.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |